- https://www.novartis.com/news/novartis-financial-results-q2-2021
Novartis announced the company’s financial results for the second quarter and first half of 2021.
- https://www.novartis.com/news/novartis-hematology-relentless-pursuit-cure
Novartis is committed to transforming the lives of people living with blood cancers and serious blood disorders.
- https://www.novartis.com/news/novartis-condemns-terrorist-actions-against-people-israel-and-loss-innocent-lives
- https://www.novartis.com/news/novartis-expands-humanitarian-efforts-ukraine-through-donation-essential-medicines
- https://www.novartis.com/news/novartis-announces-first-european-donation-hydroxychloroquine-switzerland
- https://www.novartis.com/news/novartis-coronavirus-update-supply-chain-response-measures-efpia-rd-call
- https://www.novartis.com/news/expanding-car-t-manufacturing-australia
Cell Therapies Pty Ltd has become the first approved CAR-T commercial manufacturing site in Australia, providing potentially faster access to CAR-T therapies to eligible patients in the region with life-threatening blood cancers.
Novartis global commercial CAR-T manufacturing footprint now spans four continents, bringing these transformative therapies closer to patients and healthcare professionals around the world. - https://www.novartis.com/news/novartis-and-red-cross-partner-tackle-chronic-diseases-refugee-populations
Novartis is partnering with the International Committee of the Red Cross (ICRC) to improve care and treatment for Syrian refugees in Lebanon suffering from chronic diseases.
- https://www.novartis.com/news/mission-transform-planetary-health
The first One Young World – Novartis Caucus took place virtually on February 11, 2021.
- https://www.novartis.com/news/novartis-announces-flexible-return-office-and-site-field-activities-starting-may-11-2020
Pagination
- ‹ Previous page
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- …
- 19
- › Next page